Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Hematology|June 5, 2015
Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22)Lijun Wen, Jing Xia, Qinrong Wang, et al.
Frontiers in Oncology|October 28, 2021
Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature ReviewYingxin Sun, Yifeng Cai, Jia Chen, et al.
Experimental Hematology|August 22, 2008
Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alterationHuiying Qiu, Yongquan Xue, Jun Zhang, et al.
International Journal of Laboratory Hematology|August 8, 2023
Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysisYanglin Cao, Yan Chen, Tingting Tao, et al.
Cancer Genetics|May 4, 2011
Establishment and characterization of a novel acute myeloid leukemia cell line, JIH-4, carrying a t(16;21)(p11.2;q22) and expressing the FUS-ERG fusionHui Jiang, Huiying Qiu, Yongquan Xue, et al.
Hematology (Amsterdam, Netherlands)|July 18, 2015
Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinibYanhua Yue, Xiaomin Gui, Xuefeng He, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|February 9, 2010
[Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent]Yafang Wu, Yongquan Xue, Suning Chen, et al.
Cancer Genetics|November 5, 2016
Clinical and molecular cytogenetic studies in ten patients with hematological malignancies characterized by t(20;21)(q11;q11) resulted from del(20q)Chunxiao Wu, Jun Zhang, Shuxiao Bai, et al.
Molecular Carcinogenesis|November 2, 2022
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two casesYan Chen, Qian Wang, Jiannong Cen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 27, 2014
[A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes]Xiaomin Gui, Jinlan Pan, Huiying Qiu, et al.
Pageof 9